(Q33366499)

26 July 2017

0 references

1 reference

title

Consequence or coincidence? The occurrence, pathogenesis and significance of autoimmune manifestations after viral vaccines (English)

1 reference

26 July 2017

Ami Schattner

1

1 reference

PubMed ID

15917108

26 July 2017

language of work or name

English

0 references

publication date

7 April 2005

1 reference

26 July 2017

1 reference

26 July 2017

23

1 reference

26 July 2017

30

1 reference

26 July 2017

3876-3886

1 reference

Molecular mimicry and autoimmunity.

26 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.005

The elusive case for a role of mimicry in autoimmune diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.005

Current controversies in vaccination: vaccine safety

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.005

Type 1A diabetes induced by infection and immunization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.005

Vaccination and autoimmune disease: what is the evidence?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.005

The case for routine childhood vaccination against hepatitis A

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.005

Polyarteritis nodosa and extrahepatic manifestations of HBV infection: the case against autoimmune intervention in pathogenesis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.005

Prolonged hepatitis B surface antigenemia after vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.005

Cytokine-dependent anti-viral role of CD4-positive T cells in therapeutic vaccination against chronic hepatitis B viral infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.005

The antibody response to HBs antigen is regulated by coordinated Th1 and Th2 cytokine production in healthy neonates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.005

MxA gene expression after live virus vaccination: a sensitive marker for endogenous type I interferon

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.005

Rheumatic disorders developed after hepatitis B vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.005

Sjögren's syndrome occurring after hepatitis B vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.005

Hepatitis B vaccine associated with erythema nodosum and polyarthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.005

Encephalitis after hepatitis B vaccination: recurrent disseminated encephalitis or MS?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.005

Postmarketing surveillance for neurologic adverse events reported after hepatitis B vaccination. Experience of the first three years

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.005

Postvaccinal inflammatory neuropathy: peripheral nerve biopsy in 3 cases.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.005

Immune thrombocytopenic purpura after recombinant hepatitis B vaccine: retrospective study of seven cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.005

Immunologic reactions and hepatitis B vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.005

A shadow falls on hepatitis B vaccination effort

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.005

Hepatitis B vaccination and the risk of multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.005

Vaccinations and the risk of relapse in multiple sclerosis. Vaccines in Multiple Sclerosis Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.005

Vaccinations and Risk of Central Nervous System Demyelinating Diseases in Adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.005

Lack of association between early childhood immunizations and beta-cell autoimmunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.005

No evidence that vaccines cause insulin dependent diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.005

No increase in demyelinating diseases after hepatitis B vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.005

School-based hepatitis B vaccination programme and adolescent multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.005

Decline of mumps antibodies in type 1 (insulin-dependent) diabetic children and a plateau in the rising incidence of type 1 diabetes after introduction of the mumps-measles-rubella vaccine in Finland. Childhood Diabetes in Finland Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.005

Childhood vaccinations, vaccination timing, and risk of type 1 diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.005

Risk factors for development of systemic lupus erythematosus: allergies, infections, and family history

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.005

Safety of immunisation and adverse events following vaccination against hepatitis B.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.005

Pathogenesis, diagnosis, and treatment of acute disseminated encephalomyelitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.005

Childhood autoimmune neurologic diseases of the central nervous system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.005

Persistent measles virus genome in autoimmune chronic active hepatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.005

Persistent rubella virus infection associated with chronic arthritis in children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.005

A new look at viruses in type 1 diabetes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.005

Neurologic disorders after measles-mumps-rubella vaccination.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.005

Measles vaccination and Guillain-Barré syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.005

Risk of aseptic meningitis after measles, mumps, and rubella vaccine in UK children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.005

Outbreak of aseptic meningitis associated with mass vaccination with a urabe-containing measles-mumps-rubella vaccine: implications for immunization programs.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.005

Acute thrombocytopenic purpura following measles, mumps and rubella vaccination. A report on 23 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.005

Purpura in Congenital and Acquired Rubella

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.005

Postpartum rubella immunization: association with development of prolonged arthritis, neurological sequelae, and chronic rubella viremia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.005

Absence of an association between rubella vaccination and arthritis in underimmune postpartum women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.005

Mumps, measles, and rubella vaccine and the incidence of autism recorded by general practitioners: a time trend analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.005

No major association of breast-feeding, vaccinations, and childhood viral diseases with early islet autoimmunity in the German BABYDIAB Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.005

Measles-mumps-rubella and other measles-containing vaccines do not increase the risk for inflammatory bowel disease: a case-control study from the Vaccine Safety Datalink project

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.005

Guillain-Barre syndrome following vaccination in the National Influenza Immunization Program, United States, 1976--1977

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.005

Reassessment of the Association between Guillain-Barré Syndrome and Receipt of Swine Influenza Vaccine in 1976–1977: Results of a Two-State Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.005

The Guillain-Barré syndrome and the 1992-1993 and 1993-1994 influenza vaccines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.005

Influenza vaccination and Guillain Barre syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.005

Use of the inactivated intranasal influenza vaccine and the risk of Bell's palsy in Switzerland

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.005

Letter: Polyarteritis after influenza vaccination.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.005

A possible association between influenza vaccination and small-vessel vasculitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.005

Giant cell arteritis after influenza vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.005

Rheumatic complications of influenza vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.005

The spectrum of antecedent infections in Guillain-Barre syndrome: A case-control study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.005

Guillain-Barré syndrome following influenza vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.005

Nationwide oral poliovirus vaccination campaign and the incidence of Guillain-Barré Syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.005

Epidemiology of Guillain-Barré syndrome in children: relationship of oral polio vaccine administration to occurrence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.005

The effectiveness of the varicella vaccine in clinical practice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.005

Postlicensure safety surveillance for varicella vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.005

Epidemiology of autoimmune reactions induced by vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.005

Neurological complication of antirabies vaccination in São Paulo, Brazil. Clinical and therapeutical aspects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.005

Neuroparalytic accidents of antirabies vaccination with suckling mouse brain vaccine. Clinical and pathologic study of 21 cases.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.005

Myelin basic protein as an encephalitogen in encephalomyelitis and polyneuritis following rabies vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.005

Anticardiolipin antibodies in patients with rabies vaccination induced neurological complications and other neurological diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.005

Immunologic studies in subjects with a serum sickness-like illness after immunization with human diploid cell rabies vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.005

The smallpox vaccine and postvaccinal encephalitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.005

Myopericarditis following smallpox vaccination among vaccinia-naive US military personnel

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.005

The risk of vaccination--the importance of "negative" studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.005

Content and design attributes of antivaccination web sites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.005

Can immunization precipitate connective tissue disease? Report of five cases of systemic lupus erythematosus and review of the literature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.005

Vaccination and autoimmunity-'vaccinosis': a dangerous liaison?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.005

Molecular characterization of virus-induced autoantibody responses.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.005

Extrahepatic manifestations of hepatitis C infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.005

Evidence for coxsackievirus infection in primary Sjögren's syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.005

From infection to autoimmunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.005

A viral epitope that mimics a self antigen can accelerate but not initiate autoimmune diabetes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.005

Exacerbation of autoantibody-mediated thrombocytopenic purpura by infection with mouse viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.005

Exacerbation of autoantibody-mediated hemolytic anemia by viral infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.005

Can enteroviruses cause type 1 diabetes?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.005

Persistent infection with Theiler's virus leads to CNS autoimmunity via epitope spreading

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.005

Diabetes induced by Coxsackie virus: initiation by bystander damage and not molecular mimicry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.005

Molecular mimicry by herpes simplex virus-type 1: autoimmune disease after viral infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.005

A virus-induced molecular mimicry model of multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.005

Lymphokines in autoimmunity--a critical review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.005

Macrophagic myofasciitis lesions assess long-term persistence of vaccine-derived aluminium hydroxide in muscle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.005

Animal models for autoimmune demyelinating disorders of the nervous system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.005

Neurologic complications associated with influenza vaccination: two adult cases.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.005

Two episodes of leukoencephalitis associated with recombinant hepatitis B vaccination in a single patient.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.005

7 January 2021

Vaccines and vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.005

Balancing benefits and harms in health care: Observational data on harm are already included in systematic reviews

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.005

Influenza immunization in systemic lupus eruthematosus. A double-blind trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.005

In vitro response to influenza immunisation by peripheral blood mononuclear cells from patients with systemic lupus erythematosus and other autoimmune diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.005

A multicenter, randomized, double-blind, placebo-controlled trial of influenza immunization in multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.005

Neurological complications of swine influenza vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.005

inferred from DOI database lookup

7 January 2021

based on heuristic

Patients who develop inflammatory polyarthritis (IP) after immunization are clinically indistinguishable from other patients with IP.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.005

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VACCINE.2005.03.005

1 reference

26 July 2017

1 reference

PubMed ID

15917108